SCHEDULE: FMR LLC Boosts IMMUNOME Stake to 15%
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson reported beneficial ownership of 15.0% of IMMUNOME INC's common stock as of September 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 13,056,709.11 shares of IMMUNOME INC common stock.
- This ownership represents 15.0% of the total outstanding common stock of IMMUNOME INC.
- FMR LLC holds sole voting power over 13,054,983.00 shares and sole dispositive power over 13,056,709.11 shares.
- Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is deemed to beneficially own the same 13,056,709.11 shares with sole dispositive power.
- Fidelity Growth Company Commingled Pool, an entity within the FMR LLC group, holds 5,133,293.00 shares, representing 5.9% of IMMUNOME INC's common stock.
Sentiment
Score: 5
Explanation: This filing is a routine beneficial ownership report and does not contain information to indicate a positive or negative sentiment regarding the issuer's performance or outlook. It is a factual disclosure of an institutional stake.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a significant ownership stake by a major institutional investor, FMR LLC, in a publicly traded company, IMMUNOME INC. It does not provide specific industry analysis or context regarding IMMUNOME INC's operations or market position.
Stakeholder Impact
- Increased institutional ownership by FMR LLC, a prominent investment firm, may signal confidence in IMMUNOME INC to existing and potential shareholders, potentially influencing market perception.
Key Dates
| Date | Description |
|---|---|
| January 3, 2023 | Effective date of Power of Attorney for FMR LLC and its subsidiaries. |
| January 10, 2023 | Filing date for Exhibit 24 to the Schedule 13G by FMR LLC, referencing the Power of Attorney. |
| January 26, 2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| January 31, 2023 | Filing date for Exhibit 24 to the Schedule 13G by FMR LLC, referencing Abigail P. Johnson's Power of Attorney. |
| September 30, 2025 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| October 6, 2025 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
IMMUNOME INC, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.